<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092017000300136</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Uso de soluciones intravenosas y su relación con la lesión renal aguda en la Unidad de Terapia Intensiva]]></article-title>
<article-title xml:lang="en"><![CDATA[Intravenous fluids and its relationship with acute kidney injury in the Intensive Care Unit]]></article-title>
<article-title xml:lang="pt"><![CDATA[Uso de soluções intravenosas e sua relação com a lesão renal aguda na Unidade de Terapia Intensiva]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rentería Díaz]]></surname>
<given-names><![CDATA[Faustino J]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zaragoza Galván]]></surname>
<given-names><![CDATA[José J]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cerón Díaz]]></surname>
<given-names><![CDATA[Ulises W]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Español de México Unidad de Terapia Intensiva ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>3</numero>
<fpage>136</fpage>
<lpage>139</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092017000300136&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092017000300136&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092017000300136&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La lesión renal aguda se define como una elevación de la creatinina superior a 0.3 mg/dL o una disminución en los flujos urinarios en las últimas seis horas en cualquier paciente.  Métodos:  Sostuvimos la hipótesis de que los pacientes admitidos en la Unidad de Terapia Intensiva (UTI) durante 2013 presentaban mayor incidencia de lesión renal aguda, puesto que eran reanimados con mayor cantidad de solución salina al 0.9% que los pacientes ingresados en la actualidad. Comparamos dos grupos de pacientes en dos periodos distintos (años 2013 y 2015). Se recabaron diariamente datos sobre el balance de líquidos (BL), criterios de lesión renal (LR) y tipo y cantidades de soluciones administradas.  Resultados:  Durante el periodo entre julio y agosto de 2013 se incluyó un total de 30 pacientes y durante el periodo comprendido entre julio y agosto de 2015 se incluyeron 36, obteniendo un tamaño de muestra de 66 pacientes (n = 66). No se encontró asociación estadísticamente significativa en cuanto al tipo y cantidad de solución cristaloide administrada con respecto a la presencia de lesión renal aguda (p = 0.8) y días de estancia en la UTI (p = 0.45). Se observó asociación estadísticamente significativa entre lesión renal y el uso de coloides como solución intravenosa (p = 0.01).  Conclusiones:  Actualmente se tiene una tendencia a utilizar más soluciones intravenosas balanceadas, la lesión renal aguda debe prevenirse en la UTI.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Acute Kidney Injury (AKI) is defined as an elevation of serum creatinine of 0.3 mg/dL and more, or as the presence of low urine output for less tan 0.3 mL/kg/hour for at least six hours.  Methods:  We had the hypothesis that the patients atmitted to the Intensive Care Unit (ICU) during 2013 used to have high incidence of AKI because they were resucitated with more saline 0.9% solution than patients today. We compare two groups of patients in different periods of time (years 2013 and 2015). We recorded every day different data like fluid balance (FB), cirteria of acute kidney injury (AKI) and type and quantity of intravenous fluids.  Results:  During the period of July-August 2013 we included 30 patients, and during the lapse of time of July-August 2015 we included 36 patients, for a total number of 66 patients (n = 66). There was no statistic association between the type or the quantity of cristalloid intravenous fluid administered with the incidence of AKI (p = 0.8) and the lenght of ICU stay (p = 0.45). We found only statistic significance between AKI and the use of colloids as an intravenous fluid (p = 0.01).  Conclusions:  Nowadays we have the trend of use more balance intravenous fluids, the acute kidney injury has to be forewarned and avoided in the ICU.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A lesão renal aguda é definida como uma elevação da creatinina de 0.3 mg/dL ou uma diminuição do fluxo urinário nas últimas 6 horas em qualquer paciente.  Métodos:  Nossa hipótese foi que os pacientes admitidos na Unidade de Terapia Intensiva durante 2013 apresentaram uma maior incidência de lesão renal aguda, devido a que foram reanimados com maior quantidade de solução salina 0.9% que os pacientes admitidos atualmente. Comparou-se dois grupos de pacientes em dois períodos de tempo diferentes (2013 e 2015). Recoletamos diariamente os dados sobre o balance de líquidos (BL), critérios de lesão renal (LR), tipo e quantidades de soluções administradas.  Resultados:  Durante o período de Julho-Agosto de 2013, foram incluídos um total de 30 pacientes e durante o período compreendido entre Julho-Agosto de 2015 foram incluídos 36 pacientes, dando um tamanho de amostra de 66 pacientes (n = 66). Não encontramos uma associação estatisticamente significativo em quanto ao tipo e quantidade de solução cristalóide administrada, no que diz respeito a apresentação da lesão renal aguda (p = 0.8) e dias de permanência na UTI (p = 0.45). Encontramos uma associação estatisticamente significativa entre a lesão renal e o uso de colóides como solução intravenosa (p = 0.01).  Conclusões:  Atualmente existe uma tendência para utilizar soluções intravenosas mais equilibradas, devemos prevenir a lesão renal aguda na UTI.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Lesión renal aguda]]></kwd>
<kwd lng="es"><![CDATA[soluciones intravenosas]]></kwd>
<kwd lng="es"><![CDATA[hipercloremia]]></kwd>
<kwd lng="es"><![CDATA[terapia intensiva]]></kwd>
<kwd lng="en"><![CDATA[Acute kidney injury]]></kwd>
<kwd lng="en"><![CDATA[intravenous fluids]]></kwd>
<kwd lng="en"><![CDATA[hyperchloremia]]></kwd>
<kwd lng="en"><![CDATA[Intensive Care Unit]]></kwd>
<kwd lng="pt"><![CDATA[Lesão renal aguda]]></kwd>
<kwd lng="pt"><![CDATA[soluções intravenosas]]></kwd>
<kwd lng="pt"><![CDATA[hipercloremia]]></kwd>
<kwd lng="pt"><![CDATA[terapia intensiva]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myburgh]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mythen]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resuscitation fluids]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2013</year>
<volume>369</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1243-51</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent 'pre-renal' acute kidney injury]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2014</year>
<volume>86</volume>
<page-range>1096-105</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<source><![CDATA[Íbidem]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yunos]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Story]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bench-to-bedside review chloride in critical illness]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2010</year>
<volume>14</volume>
<page-range>226</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chertow]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Burdick]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Honour]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bonventre]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute kidney injury, mortality, length of stay, and costs in hospitalized patients]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2005</year>
<volume>16</volume>
<page-range>3365-70</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chappell]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Conzen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkes]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Rehm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Small-volume resuscitation with hyperoncotic albumin a systematic review of randomized clinical trials]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>R34</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent "pre-renal" acute kidney injury]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2014</year>
<volume>86</volume>
<page-range>1096-105</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perel]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colloids versus crystalloids for fluid resuscitation in critically ill patients]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2011</year>
<volume>3</volume>
<page-range>CD000567</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chappell]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Conzen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkes]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Rehm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Small-volume resuscitation with hyperoncotic albumin a systematic review of randomized clinical trials]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>R34</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chertow]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Burdick]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Honour]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bonventre]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute kidney injury, mortality, length of stay, and costs in hospitalized patients]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2005</year>
<volume>16</volume>
<page-range>3365-70</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[de Pont]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Sakr]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Spies]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Reinhart]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A positive fluid balance is associated with a worse outcome in patients with acute renal failure]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>R74</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivers]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Havstad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ressler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Muzzin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Knoblich]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early goal-directed therapy in the treatment of severe sepsis and septic shock]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2001</year>
<volume>345</volume>
<page-range>1368-77</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<collab>The ARISE Investigators and the ANZICS Clinical Trials Group</collab>
<article-title xml:lang=""><![CDATA[Goal-directed resuscitation for patients with early septic shock]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2014</year>
<volume>371</volume>
<page-range>1496-506</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chappell]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Conzen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkes]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Rehm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Small-volume resuscitation with hyperoncotic albumin a systematic review of randomized clinical trials]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>R34</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perel]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colloids versus crystalloids for fluid resuscitation in critically ill patients]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2011</year>
<volume>3</volume>
<page-range>CD000567</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent "pre-renal" acute kidney injury]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2014</year>
<volume>86</volume>
<page-range>1096-105</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yunos]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hegarty]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Story]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2012</year>
<volume>308</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1566-72</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nadeau-Fredette]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fluid management and use of diuretics in acute kidney injury]]></article-title>
<source><![CDATA[Adv Chronic Kidney Dis]]></source>
<year>2013</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-55</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godina]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchardb]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mehtac]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fluid balance in patients with acute kidney injury emerging concepts]]></article-title>
<source><![CDATA[Nephron Clin Pract]]></source>
<year>2013</year>
<volume>123</volume>
<page-range>238-45</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yunos]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Story]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bench-to-bedside review chloride in critical illness]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2010</year>
<volume>14</volume>
<page-range>226</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waikar]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Chertow]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis, epidemiology and outcomes of acute kidney injury]]></article-title>
<source><![CDATA[Clin J Am Soc Nephrol]]></source>
<year>2008</year>
<volume>3</volume>
<page-range>844-61</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qiao]]></surname>
<given-names><![CDATA[Shi]]></given-names>
</name>
</person-group>
<source><![CDATA[Acute renal injury in sodium taurocholate-induced severe acute pancreatitis by inhibiting ROS and NF-B Pathway]]></source>
<year></year>
<publisher-loc><![CDATA[Hindawi ]]></publisher-loc>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
